Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact.
Jennifer Ohn, MPH
Advertisement
Articles by Jennifer Ohn, MPH
Advertisement
Latest Updated Articles
- Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy
Published: May 13th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
3
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
4
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
5
